Market research reports, consulting: Global Market Insights Inc.
We use cookies to enhance user experience. (Privacy Policy)

Clinical Trial Equipment & Ancillary Solutions Market Analysis

Report ID: GMI9268
   |
Published Date: April 2024
 | 
Report Format: PDF

Download free sample

Clinical Trial Equipment & Ancillary Solutions Market Analysis

Clinical Trial Equipment & Ancillary Solutions Market, By Type, 2021 – 2032  (USD Billion)

Based on type, the market is categorized into diagnostic equipment, laboratory instruments, and ancillary solutions. The diagnostic equipment segment is anticipated to reach USD 1.1 billion by 2032.
 

  • Diagnostic equipment holds a dominant position in the market due to its critical role in patient assessment, disease diagnosis, and monitoring throughout clinical trials. These tools include various imaging machines, diagnostic tests, and monitoring devices essential for gathering accurate data and assessing patient health status. Thus, widespread adoption of diagnostic equipment in clinical trials is expected to spur the segmental growth.
     

Clinical Trial Equipment & Ancillary Solutions Market, By Service (2023)

Based on service, the clinical trial equipment & ancillary solutions market is classified into rental & leasing services, supply and logistics services, regulatory compliance services, and software services. The supply and logistics services segment is projected to hold the largest market share of 43.1% in 2023 and is expected to maintain dominance throughout the analysis period.
 

  • As the pharmaceutical and biotechnology industries continue to expand their research and development efforts, there has been a surge in the demand for efficient and reliable supply chain solutions to support these trials. This trend is fueled by several factors, including the rising prevalence of complex and specialized therapies, globalization of clinical trials, and the imperative to expedite drug development processes. Consequently, pharmaceutical companies, contract research organizations (CROs), and other stakeholders are increasingly relying on specialized logistics providers to ensure the timely and seamless delivery of investigational drugs, medical devices, and other critical supplies to clinical trial sites worldwide. This burgeoning demand for comprehensive clinical trial supply and logistics is thus driving the market growth.
     

Based on the end-user, the clinical trial equipment & ancillary solutions market is segmented into pharmaceutical & biotechnology companies, contract research organizations (CROs), medical device companies, and other end-users. The pharmaceutical & biotechnology companies segment accounted for the largest revenue share in the market expected to account for USD 1.4 billion by 2032.
 

  • The pharmaceutical & biotechnology companies drive demand for various equipment and ancillary services essential for trial conduct, including diagnostic tools, monitoring devices, and logistical solutions. Their substantial R&D investments, coupled with their extensive networks and resources, position them as dominant players shaping the market landscape.
     

North America Clinical Trial Equipment & Ancillary Solutions Market, 2021 – 2032  (USD Million)

U.S. dominated the North American clinical trial equipment & ancillary solutions market accounting for USD 730.7 million in 2023 and is anticipated to show significant growth over the analysis period.
 

  • The pharmaceutical and biotechnology sectors in the U.S. are thriving, hosting numerous companies engaged in clinical trials worldwide. Also, the favorable regulations and substantial R&D investments foster innovation in the U.S. clinical trial equipment and ancillary services industry.
     
  • Further, leading market players' presence and strategic approaches to maintain market viability have gained traction within the country. For instance, in March 2023, Almac Group's invested USD 65 million to expand supply-chain services for clinical trials in Montgomery County, Pennsylvania, which is anticipated to further stimulate the U.S. market growth.
     

Germany exhibited a high growth potential in the European clinical trial equipment & ancillary solutions market.
 

  • Germany holds a prominent position in the European market, supported by its advanced healthcare infrastructure and strong pharmaceutical sector. The country is known for its high-quality medical research institutions and clinical trial sites, attracting multinational pharmaceutical companies and CROs. Therefore, usage of different ancillary solutions will augment the country level market growth.
     

The Asia Pacific clinical trial equipment & ancillary solutions market is poised for rapid growth with a CAGR of 8.0% during the forecast period.
 

  • The region's burgeoning pharmaceutical industry, increasing clinical trial activities, and supportive regulatory environment contribute to this trend. For instance, according to research, the Asia-Pacific accounted for the highest proportion of early-stage phase I trials at 28%. The majority of APAC trials were in phase II (39.3%). Thus, the increasing number of trial activities anticipates to a surge in the demand for clinical equipment and ancillary solutions to meet process requirements, driving market growth in the coming years.
     
  • Additionally, advancements in healthcare infrastructure and rising R&D funding further bolster market expansion in the Asia Pacific region.
     

India gained traction in the clinical trial equipment & ancillary solutions market anticipating substantial growth during the analysis period.
 

  • India is an emerging market for clinical trials, driven by its large patient population, cost-effective healthcare services, and skilled workforce, thereby attracting domestic and international pharmaceutical companies. Further, rapidly growing healthcare market and supportive government policies are driving the expansion of clinical trial activities and demand for related equipment and solutions in the country.
Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
What is propelling the demand for clinical trial diagnostic equipment?
The diagnostic equipment segment in the market will reach USD 1.1 billion by 2032, owing to increasing emphasis on precision medicine and personalized healthcare.
What is the size of the clinical trial equipment & ancillary solutions market?
Who are the leading clinical trial equipment & ancillary solution providers?
How large is the clinical trial equipment & ancillary solutions market in North America?
Clinical Trial Equipment & Ancillary Solutions Market Scope

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Globalization of clinical trials

3.2.1.2    Growing demand for outsourcing clinical trials to CROs

3.2.1.3    Rise in government and non-government funding for clinical trials

3.2.1.4    Focus on patient-centric trials

3.2.1.5    Growing technology advancements

3.2.2    Industry pitfalls & challenges

3.2.2.1    Complex and stringent regulatory requirements

3.2.2.2    Limited infrastructure in developing countries

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Clinical trial volume, by region

3.6    Porter's analysis

3.7    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company matrix analysis

4.3    Competitive analysis of major market players

4.4    Competitive positioning matrix

4.5    Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)

5.1    Key trends

5.2    Diagnostic equipment

5.3    Laboratory instruments

5.4    Ancillary solutions

Chapter 6   Market Estimates and Forecast, By Service, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    Rental & leasing services

6.3    Supply and logistics services

6.4    Regulatory compliance services

6.5    Software services

Chapter 7   Market Estimates and Forecast, By End-user, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    Pharmaceutical & biotechnology companies

7.3    Contract research organizations (CROs)

7.4    Medical device companies

7.5    Other end-users

Chapter 8   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

8.1    Key trends

8.2    North America

8.2.1   U.S.

8.2.2   Canada

8.3    Europe

8.3.1   Germany

8.3.2   UK

8.3.3   France

8.3.4   Spain

8.3.5   Italy

8.3.6   The Netherlands

8.3.7   Rest of Europe

8.4    Asia Pacific

8.4.1   Japan

8.4.2   China

8.4.3   India

8.4.4   Australia

8.4.5   South Korea

8.4.6   Rest of Asia Pacific

8.5    Latin America

8.5.1   Brazil

8.5.2   Mexico

8.5.3   Rest of Latin America

8.6    Middle East and Africa

8.6.1   Saudi Arabia

8.6.2   South Africa

8.6.3   UAE

8.6.4   Rest of Middle East and Africa

Chapter 9   Company Profiles

9.1    Andwin Scientific

9.2    Ancillare, LP.

9.3    AXELERIST FINANCIAL

9.4    Biocair

9.5    ICON plc

9.6    Imperial CRS, LLC.

9.7    Marken

9.8    MESM UK.

9.9    Myonex

9.10    NUVISAN

9.11    Oximio

9.12    Parexel International (MA) Corporation

9.13    Quipment SAS

9.14    Thermo Fisher Scientific Inc.

   

Authors: Mariam Faizullabhoy, Gauri Wani
Buy Now
$4,123 $4,850
15% off
$4,280 $5,350
20% off
$5,845 $8,350
30% off
    Buy now
Premium Report Details

Base Year: 2022

Companies covered: 14

Tables & Figures: 228

Countries covered: 22

Pages: 160

Download Free Sample

Top